Jackson DJ, Heaney LG, Humbert M, Kent BD, et al. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study. Lancet 2023 Dec 7:S0140-6736(23)02284-5. doi: 10.1016/S0140-6736(23)02284.
PMID: 38071986